On January 18, 2021, the Ministry of Health and Medical Industry of Turkmenistan registered the “Sputnik V” vaccine and issued a corresponding certificate.
Kirill Dmitriev, General Director of the Russian Direct Investment Fund (RDIF), said that “Turkmenistan became the first country in Central Asia to officially approve the use of the “Sputnik V” vaccine on its territory. The partners highly appreciated the safety and effectiveness of the vaccine, which today is one of the world's leading drugs in the fight against coronavirus and has already been approved by government regulators in different regions of the world. We are convinced that vaccination of the population with the proven “Sputnik V” drug, created on the basis of a well-studied platform of human adenoviral vectors, is one of the key elements in preventing the spread of coronavirus infection".
To date, the “Sputnik V” vaccine has been approved for use in more than 10 countries around the world.